2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Breast Neoplasms
189
Neoplasm Metastasis
24
Neoplasms
23
Ovarian Neoplasms
12
Sarcoma
10
Pancreatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Melanoma
7
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Head and Neck Neoplasms
6
Carcinoma, Renal Cell
6
Breast Diseases
6
Recurrence
5
Medulloblastoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Sarcoma, Ewing
4
Neoplasms by Site
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Glioma
4
Glioblastoma
4
Colonic Neoplasms
4
Interventions
Nivolumab
6
Imatinib Mesylate
4
Ipilimumab
3
Cetuximab
3
pembrolizumab
2
palbociclib
2
Specimen Handling
2
Radiotherapy
2
Radiosurgery
2
Protons
2
Proton Therapy
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
tazemetostat
1
spartalizumab
1
relatlimab
1
nilotinib
1
camrelizumab
1
avelumab
1
atezolizumab
1
apatinib
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Thiotepa
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Chordoma
×
palbociclib
×
Clear all
NCT03242382
2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
40 enrolled
NCT03110744
2023-03-27
NCT-PMO-1601
University Hospital Heidelberg
Phase 2
Completed
43 enrolled